<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8" />
    <title>Elisence – Phase 8: Advanced Health Engine (AHE)</title>
    <meta name="viewport" content="width=device-width, initial-scale=1" />

    <!-- Elisa chat widget -->
    <script defer src="elisa-chat.js"></script>

    <style>
        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }

        :root {
            --bg-space: radial-gradient(circle at top, #04101f 0%, #02040a 45%, #000000 100%);
            --text-main: #e8f4fc;
            --text-soft: #dbefff;
            --text-muted: #94a3b8;
            --accent: #38bdf8;
            --accent-soft: #7dd3fc;
            --card-bg: rgba(15, 23, 42, 0.96);
            --card-border: rgba(90, 185, 255, 0.9);
        }

        body {
            min-height: 100vh;
            font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
            background: var(--bg-space);
            color: var(--text-main);
            overflow-x: hidden;
            line-height: 1.6;
        }

        /* ===== top dot & label (مثل index) ===== */
        .top-dot {
            position: fixed;
            left: 18px;
            top: 18px;
            width: 14px;
            height: 14px;
            border-radius: 50%;
            background: radial-gradient(circle, #34c8ff, #0065ff 65%, #000c28 100%);
            box-shadow: 0 0 18px rgba(0, 170, 255, 0.9);
            z-index: 900;
        }

        .top-dot-label {
            position: fixed;
            left: 40px;
            top: 16px;
            font-size: 14px;
            letter-spacing: 0.22em;
            text-transform: uppercase;
            color: #a9d4ff;
            z-index: 900;
        }

        /* ===== side navigation – DESKTOP (کپی مستقیم از index) ===== */
        .side-nav {
            position: fixed;
            right: 32px;
            top: 50%;
            transform: translateY(-50%);
            display: flex;
            flex-direction: column;
            gap: 12px;
            z-index: 999;
        }

        .nav-btn {
            display: block;
            padding: 13px 38px;
            border-radius: 999px;
            text-decoration: none;
            font-size: 14px;
            letter-spacing: 0.14em;
            text-transform: uppercase;
            color: #e3f2ff;
            background: radial-gradient(circle at top,
                rgba(0, 130, 255, 0.45),
                rgba(0, 10, 35, 0.97));
            border: 1px solid rgba(90, 185, 255, 0.9);
            box-shadow:
                0 0 16px rgba(0, 130, 255, 0.95),
                0 0 34px rgba(0, 40, 120, 0.95);
            transition:
                transform 0.2s ease,
                box-shadow 0.2s ease,
                background 0.2s ease,
                padding 0.2s ease;
        }

        .nav-btn:hover {
            transform: translateX(-4px);
            padding-right: 44px;
            box-shadow:
                0 0 22px rgba(0, 190, 255, 1),
                0 0 46px rgba(0, 80, 200, 1);
            background: radial-gradient(circle at top,
                rgba(0, 170, 255, 0.7),
                rgba(0, 25, 80, 1));
        }

        .nav-btn:active {
            transform: translateX(-2px) scale(0.99);
        }

        /* ===== layout wrapper (هم استایل فاز ۹) ===== */
        .page-wrapper {
            max-width: 1200px;
            margin: 0 auto;
            padding: 96px 1.8rem 72px 1.8rem;
        }

        .hero-area {
            margin-bottom: 2.4rem;
        }

        .phase-hero-card {
            background: radial-gradient(circle at top left,
                rgba(0, 156, 255, 0.35),
                rgba(15, 23, 42, 0.98));
            border-radius: 26px;
            border: 1px solid var(--card-border);
            box-shadow:
                0 0 45px rgba(0, 170, 255, 0.85),
                0 0 120px rgba(0, 80, 200, 0.65);
            padding: 1.8rem 1.9rem;
        }

        .phase-hero-inner {
            display: flex;
            gap: 1.8rem;
            align-items: stretch;
        }

        .phase-hero-logo-box {
            flex: 0 0 290px;
            border-radius: 22px;
            background: radial-gradient(circle at top, #0b1220, #020617);
            display: flex;
            align-items: center;
            justify-content: center;
            padding: 0.75rem;
            box-shadow:
                0 0 24px rgba(15, 23, 42, 0.9),
                0 0 40px rgba(15, 23, 42, 0.9);
        }

        .phase-hero-logo {
            width: 100%;
            max-width: 360px;
            height: auto;
            border-radius: 18px;
            box-shadow: 0 0 28px rgba(15, 23, 42, 0.95);
        }

        .phase-hero-text-box {
            flex: 1;
            display: flex;
            flex-direction: column;
            justify-content: center;
        }

        .phase-label {
            font-size: 0.78rem;
            text-transform: uppercase;
            letter-spacing: 0.18em;
            color: var(--text-muted);
            margin-bottom: 0.3rem;
        }

        .phase-title {
            font-size: 1.9rem;
            letter-spacing: 0.06em;
            text-transform: uppercase;
            color: #f9fafb;
            margin: 0 0 0.35rem 0;
        }

        .phase-subtitle {
            font-size: 0.95rem;
            letter-spacing: 0.14em;
            text-transform: uppercase;
            color: #93c5fd;
            margin-bottom: 0.6rem;
        }

        .phase-lead {
            font-size: 0.98rem;
            color: var(--text-soft);
            margin-bottom: 0.7rem;
        }

        .phase-hero-bullets {
            margin: 0.3rem 0 0 0;
            padding-left: 1.1rem;
            font-size: 0.9rem;
            color: #dbefff;
        }

        .phase-hero-bullets li {
            margin-bottom: 0.2rem;
        }

        /* ===== detail cards ===== */
        .phase-main {
            max-width: 1100px;
            margin: 0 auto;
        }

        .info-card {
            background: var(--card-bg);
            border-radius: 20px;
            border: 1px solid var(--card-border);
            box-shadow:
                0 0 22px rgba(0, 140, 255, 0.9),
                0 0 40px rgba(0, 40, 120, 0.9);
            padding: 1.8rem 1.7rem;
            margin-bottom: 1.8rem;
        }

        .info-card h2 {
            margin-top: 0;
            margin-bottom: 0.85rem;
            font-size: 1.3rem;
            color: var(--accent-soft);
        }

        .info-card h3 {
            margin-top: 1.1rem;
            margin-bottom: 0.4rem;
            font-size: 1.02rem;
            color: var(--accent);
        }

        .info-card p {
            margin: 0.35rem 0;
            font-size: 0.94rem;
            color: #e5f2ff;
        }

        .info-card ul {
            margin: 0.45rem 0 0.25rem 1.2rem;
            padding-left: 0.3rem;
        }

        .info-card li {
            margin-bottom: 0.32rem;
            font-size: 0.93rem;
        }

        .subtle {
            font-size: 0.88rem;
            color: var(--text-muted);
        }

        .highlight {
            border-left: 3px solid var(--accent);
            padding-left: 0.9rem;
            margin-top: 0.4rem;
            font-size: 0.95rem;
            color: var(--text-soft);
        }

        /* ===== responsive (مثل index) ===== */
        @media (max-width: 900px) {
            .page-wrapper {
                padding: 80px 1.2rem 80px 1.2rem;
            }

            .phase-hero-inner {
                flex-direction: column;
            }

            .phase-hero-logo-box {
                flex: 0 0 auto;
            }

            .info-card {
                padding: 1.5rem 1.35rem;
            }

            .side-nav {
                position: fixed;
                right: 50%;
                top: auto;
                bottom: 18px;
                transform: translateX(50%);
                flex-direction: row;
                flex-wrap: wrap;
                justify-content: center;
                gap: 8px;
            }

            .nav-btn {
                padding: 9px 20px;
                font-size: 11px;
                letter-spacing: 0.11em;
            }
        }
    </style>
</head>
<body>

<div class="top-dot"></div>
<div class="top-dot-label">ELISENCE</div>

<nav class="side-nav">
    <a href="index.html" class="nav-btn">Home</a>
    <a href="index.html#phases" class="nav-btn">Phases</a>
    <a href="about.html" class="nav-btn">About</a>
    <a href="story.html" class="nav-btn">Story</a>
    <a href="video.html" class="nav-btn">Videos</a>
    <a href="contact.html" class="nav-btn">Contact</a>
</nav>

<div class="page-wrapper">
    <!-- HERO -->
    <section class="hero-area">
        <div class="phase-hero-card">
            <div class="phase-hero-inner">
                <div class="phase-hero-logo-box">
                    <img src="elisence.png"
                         alt="Elisence – Global Digital Health & Humanity Platform"
                         class="phase-hero-logo">
                </div>
                <div class="phase-hero-text-box">
                    <div class="phase-label">PHASE 8</div>
                    <h1 class="phase-title">Advanced Health Engine (AHE)</h1>
                    <div class="phase-subtitle">
                        GOVERNED MEDICAL INTELLIGENCE · NATIONAL HEALTH INFRASTRUCTURE
                    </div>
                    <p class="phase-lead">
                        Phase 8 is the governed medical intelligence layer of Elisence – the point where Elisence
                        stops being an app and becomes <strong>health infrastructure</strong>. It unifies signals from
                        women’s health, blood, diabetes, behaviour, devices and environment into safe, non-diagnostic
                        intelligence for citizens, clinicians, hospitals and ministries.
                    </p>
                    <ul class="phase-hero-bullets">
                        <li>Multi-core health engine, OFF-by-default for high-risk features.</li>
                        <li>Role- and country-aware governance from day one.</li>
                        <li>Built to satisfy cautious regulators and demanding investors.</li>
                    </ul>
                </div>
            </div>
        </div>
    </section>

    <!-- DETAIL CARDS -->
    <main class="phase-main">

        <!-- 1. WHAT AHE IS -->
        <section class="info-card">
            <h2>1. What Phase 8 Actually Is</h2>
            <p>
                Phase 8 (AHE – Advanced Health Engine) is not a single score and not a monolithic “AI brain”.
                It is a <strong>governed, multi-core health engine</strong> that:
            </p>
            <ul>
                <li>Collects signals from women’s health, blood tests, diabetes, behaviour, devices and environment.</li>
                <li>Normalises and interprets them in a safe, non-diagnostic, explainable way.</li>
                <li>Produces calm, human-readable guidance for citizens and structured, auditable risk views for
                    clinicians and ministries.</li>
                <li>Runs high-risk medical features OFF by default, activatable only via explicit feature flags
                    and governance.</li>
            </ul>
            <p class="highlight">
                Mission: reduce pressure on health systems by catching risk earlier, educating citizens better,
                and turning raw data into structured, trustworthy intelligence instead of noise.
            </p>
        </section>

        <!-- 2. SEVEN-CORE MODEL -->
        <section class="info-card">
            <h2>2. Seven-Core Architecture</h2>
            <p>
                AHE is deliberately split into seven Cores. Each Core has its own risk profile, feature flags and
                governance. A problem in one Core never silently contaminates the others.
            </p>

            <h3>Core-1 — Women (11K)</h3>
            <ul>
                <li>Women’s contextual health signals (cycle, symptoms, pregnancy, menopause).</li>
                <li>Powered by Women AHE 11K with separate citizen, clinician and ministry views.</li>
            </ul>

            <h3>Core-2 — Blood / Hematology</h3>
            <ul>
                <li>Unified blood profile (<code>AHE_Blood_Profile_v1</code>) used across Women+, Diabetes, GLP-1
                    and the Risk Engine.</li>
                <li>Non-diagnostic hints around anaemia, bleeding, Rh-negative pregnancy and other safety-relevant patterns.</li>
            </ul>

            <h3>Core-3 — Diabetes &amp; Metabolic</h3>
            <ul>
                <li>Signals from glucose/A1c, weight, GLP-1 response and adherence.</li>
                <li>Patterns surfaced to clinicians and ministries; no automated prescribing.</li>
            </ul>

            <h3>Core-4 — Mental Health &amp; Wellbeing</h3>
            <ul>
                <li>Mood, energy and sleep signals tied into the Dopamine Engine.</li>
                <li>Safety rules for worrying combinations; always escalation, never diagnosis.</li>
            </ul>

            <h3>Core-5 — Kids &amp; Family</h3>
            <ul>
                <li>Family context and child-safe signals, governed by guardians.</li>
                <li>Connects motherhood journeys with Phase 10 (Kids+).</li>
            </ul>

            <h3>Core-6 — Environment / Context</h3>
            <ul>
                <li>Non-clinical context (heat, air quality, seasonality) that modulates risk interpretation.</li>
            </ul>

            <h3>Core-7 — Charts &amp; Intelligence</h3>
            <ul>
                <li>Population-level dashboards, cohort views and AE radar for ministries and providers.</li>
                <li>Fully governed; only anonymised, k-anonymous data leaves clinical scope.</li>
            </ul>

            <p class="subtle">
                Each Core has independent switches, audit trails and evidence packs. Countries can enable only the
                Cores they are comfortable with.
            </p>
        </section>

        <!-- 3. GOVERNANCE & SECURITY -->
        <section class="info-card">
            <h2>3. Governance &amp; Security — Per Country, Per Role, Per Feature</h2>
            <p>
                Phase 8 carries the heaviest security and governance layer in the Elisence architecture.
            </p>

            <h3>3.1 Country-Level Control</h3>
            <ul>
                <li>Every request carries a Session Passport / IdP token with
                    <code>user_id</code>, <code>role_v8</code>, <code>org_id</code>, <code>country_code</code>,
                    <code>access_tier</code>, <code>auth_strength</code>.</li>
                <li><code>country_code + access_tier</code> define which Cores and dashboards are allowed.</li>
                <li>Qatar, Saudi and other markets can run different activation mixes on the same engine.</li>
            </ul>

            <h3>3.2 Role-Based Security</h3>
            <ul>
                <li>Formal roles: citizen, clinician, clinic_admin, hospital_admin, ministry, research_partner.</li>
                <li>Citizens see calm explanations; clinicians see structured risk; ministries see aggregates only.</li>
                <li>Higher roles require stronger authentication (MFA, hardware keys, VPN).</li>
            </ul>

            <h3>3.3 Zero-Trust by Default</h3>
            <ul>
                <li>Gateway validates token signature, issuer, audience and expiry for every call.</li>
                <li>Minimal claims forwarded as headers (e.g. <code>X-Elisence-UserRole</code>, <code>X-Elisence-Country</code>).</li>
                <li>Any inconsistency → request rejected before touching clinical logic.</li>
            </ul>
            <p class="subtle">
                Result: regulators control who sees what, where and when — and they can turn features off in hours, not years.
            </p>
        </section>

        <!-- 4. WOMEN+ & BLOOD BACKBONE -->
        <section class="info-card">
            <h2>4. Women+ &amp; Blood as Strategic Backbones</h2>
            <p>
                Women’s health and blood are treated as first-class, not secondary signals.
            </p>

            <h3>4.1 Women AHE 11K</h3>
            <ul>
                <li>Citizen view: respectful, non-diagnostic explanations, always pushing towards professional review.</li>
                <li>Clinician view: structured risk flags, patterns and checklist-style prompts.</li>
                <li>Ministry view: population-level patterns (e.g. heavy bleeding, anaemia in pregnancy), anonymised.</li>
            </ul>

            <h3>4.2 Unified Blood Profile</h3>
            <ul>
                <li><code>AHE_Blood_Profile_v1</code> is the single schema used across Women+, Diabetes,
                    GLP-1 and Risk Engine.</li>
                <li>Non-diagnostic hints only, such as “this pattern may be consistent with low blood count – discuss with a clinician”.</li>
                <li>Blood dashboards and cohort tools exist but are OFF by default, waiting for national governance.</li>
            </ul>
        </section>

        <!-- 5. RISK ENGINE -->
        <section class="info-card">
            <h2>5. Risk Engine — Explainable, Not Black-Box</h2>
            <p>
                The Phase 8 Risk Engine is our own explainable method, influenced by open frameworks
                (e.g. cardiovascular risk scores) but not a copy of any proprietary model.
            </p>

            <h3>5.1 Clinical Logic</h3>
            <ul>
                <li>Focus on cardiovascular, metabolic, kidney and chronic disease risk.</li>
                <li>Combines demographics, long-term factors, symptoms, blood and behaviour into a governed risk picture.</li>
                <li>Outputs for clinicians: structured risk levels with “why” and “which signals drove this”.</li>
            </ul>

            <h3>5.2 Citizen vs Clinician Outputs</h3>
            <ul>
                <li><strong>Clinicians / ministries</strong> see structured risk and cohorts.</li>
                <li><strong>Citizens</strong> see no “10-year risk” numbers – only gentle prompts about lifestyle, check-ups
                    and speaking to a doctor.</li>
            </ul>
            <p class="subtle">
                This keeps AHE clinically meaningful while remaining outside high-risk device classes in most markets.
            </p>
        </section>

        <!-- 6. CHARTS & INTELLIGENCE -->
        <section class="info-card">
            <h2>6. Charts &amp; Intelligence — Core-7 as National Radar</h2>
            <p>
                Core-7 turns AHE into a “national radar” for chronic disease and Women+ health.
            </p>
            <ul>
                <li>Dashboards for diabetes, cardiovascular and kidney risk trends.</li>
                <li>Women+ dashboards for heavy bleeding, pelvic pain, pregnancy signals (aggregated only).</li>
                <li>Cohort comparisons by region, age, gender, BMI and medication type.</li>
                <li>Impact evaluation of interventions (campaigns, clinics, new protocols).</li>
                <li>Strict k-anonymity rules: small cohorts are hidden to prevent re-identification.</li>
            </ul>
            <p class="subtle">
                Built as compliance-first analytics, suitable for ministries, not as a flashy consumer BI toy.
            </p>
        </section>

        <!-- 7. DATA & VAULT -->
        <section class="info-card">
            <h2>7. Data Handling &amp; Unified Encrypted Vault</h2>
            <p>
                AHE assumes a single encrypted health vault instead of scattered databases.
            </p>
            <ul>
                <li>Encryption in transit and at rest; TLS everywhere.</li>
                <li>Unified profiles linking blood, Women+, diabetes, behaviour, devices and risk outputs.</li>
                <li>WORM audit logging for ingest, risk evaluations and dashboard access.</li>
                <li>Separation of identifiers and clinical content for GDPR / PDPL compliance.</li>
                <li>Export modes limited to anonymised, k-anonymous aggregates for research and public-health policy.</li>
            </ul>
        </section>

        <!-- 8. STAKEHOLDER MODES -->
        <section class="info-card">
            <h2>8. Stakeholder Views &amp; Use Cases</h2>

            <h3>8.1 Citizens</h3>
            <ul>
                <li>Use Elisence as a calm companion for Women+, GLP-1, sleep, mood and activity.</li>
                <li>Get simple explanations and nudges to seek help sooner.</li>
                <li>Keep full control over what is logged and what is shared.</li>
            </ul>

            <h3>8.2 Clinicians &amp; Clinics</h3>
            <ul>
                <li>Receive structured pre-visit context and risk, not unstructured chatter.</li>
                <li>See trends that are difficult to reconstruct inside a 10-minute appointment.</li>
            </ul>

            <h3>8.3 Hospitals</h3>
            <ul>
                <li>Use AHE dashboards to identify high-risk groups and prevent readmissions.</li>
                <li>Target specialist resources where impact is highest.</li>
            </ul>

            <h3>8.4 Ministries &amp; Governments</h3>
            <ul>
                <li>Deploy AHE as a national radar for chronic disease and Women+ health.</li>
                <li>Choose which Cores and dashboards are enabled in which regions.</li>
                <li>Run staged pilots before full national roll-out.</li>
            </ul>
        </section>

        <!-- 9. REGULATORY POSTURE -->
        <section class="info-card">
            <h2>9. Regulatory Posture &amp; Modes</h2>
            <p>
                AHE is designed for regulators who prefer caution and evidence.
            </p>

            <h3>9.1 Non-Medical Default Mode</h3>
            <ul>
                <li>Wellbeing and education only; no diagnoses, no dosing, no treatment plans.</li>
                <li>Safe lifestyle guidance and general explanations.</li>
            </ul>

            <h3>9.2 Medical-Adjacent Mode (Restricted)</h3>
            <ul>
                <li>Structured risk intelligence and dashboards for clinicians and ministries.</li>
                <li>High-risk modules (advanced Women 11K, stroke-like signals, blood heatmaps) behind feature flags.</li>
                <li>Fail-closed behaviour: if governance isn’t set, features return controlled 503 with roadmap text.</li>
            </ul>

            <p class="subtle">
                This keeps Elisence deployable today while leaving a clear path to higher MDR / FDA classes
                when countries are ready.
            </p>
        </section>

        <!-- 10. LIMITS & PROMISES -->
        <section class="info-card">
            <h2>10. Clear Limits &amp; Honest Promises</h2>
            <p>
                AHE deliberately does <strong>not</strong>:
            </p>
            <ul>
                <li>Replace doctors, clinics or hospitals.</li>
                <li>Give autonomous diagnoses or prescriptions.</li>
                <li>Offer emergency triage as a stand-alone service.</li>
                <li>Guarantee clinical outcomes.</li>
            </ul>
            <p class="subtle">
                Instead, Phase 8 is a governed, explainable intelligence layer that sits beside health systems,
                reduces noise, and makes it easier for professionals and ministries to do their job.
            </p>
        </section>

        <!-- 11. ONE-SENTENCE SUMMARY -->
        <section class="info-card">
            <h2>11. One-Sentence Summary</h2>
            <p>
                Phase 8 – Advanced Health Engine (AHE) is Elisence’s multi-core, governed medical intelligence
                layer: a zero-trust, multi-language, regulator-friendly engine that turns fragmented signals from
                women’s health, blood, diabetes, behaviour and environment into safe guidance for citizens and
                structured intelligence for clinicians and ministries — without ever pretending to replace a doctor.
            </p>
        </section>

    </main>
</div>

<!-- Elisa chat widget root -->
<div id="elisa-chat-root"></div>

</body>
</html>
